Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral analgesic cocktail for pain reduction during panretinal photocoagulation in diabetic retinopathy
IRCT20200915048724N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of pregabalin and acetaminophen + ibuprofen in diabetic retinopathy (DR) (4 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Pain sensation during PRP. Started Oct 2020; status: completed.
02
Drugs
pregabalinacetaminophen + ibuprofen
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on IRCT20200915048724N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200915048724N1.